Monday, March 16, 2020

Lasa Supergenerics and ICT explore Favipiravir therapy to fight Covid-19

Both the companies on Monday have announced commencement for the Development of antiviral Compound Favipiravir as Covid19 Treatment.

from India Infoline News Service https://ift.tt/2TUItfJ
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)